Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
LIN54	132660	broad.mit.edu	37	4	83905798	83905798	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	g.chr4:83905798G>C	ENST00000340417.3	-	2	577	c.200C>G	c.(199-201)aCa>aGa	p.T67R	LIN54_ENST00000442461.2_Intron|LIN54_ENST00000395283.2_Missense_Mutation_p.T67R|LIN54_ENST00000506560.1_Missense_Mutation_p.T67R|LIN54_ENST00000505397.1_Missense_Mutation_p.T67R|LIN54_ENST00000510557.1_Intron|LIN54_ENST00000446851.2_Intron|LIN54_ENST00000395282.2_Missense_Mutation_p.T67R	NM_194282.2	NP_919258.2	Q6MZP7	LIN54_HUMAN	lin-54 homolog (C. elegans)	67		NA		NA	cell cycle|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding		NA	breast(2)|endometrium(2)|kidney(3)|large_intestine(2)|lung(5)	14		Hepatocellular(203;0.114)			NA	ACTGTACACTGTGATTGGTTC	0.428		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													290	275	280	NA		NA	NA	4		NA		NA									NA				83905798		2203	4300	6503	SO:0001583	missense			ENSG00000189308	HGNC:25397	NM_194282	Approved	uc003hnx.3	NA	Q32M68|Q32M69|Q6N071|Q76B60	ENST00000340417.3	37	CCDS3599.1	.	.	.	.	.	.	.	.	.	.	G	10.28	1.306016	0.23736	.	.	ENSG00000189308	ENST00000340417;ENST00000395283;ENST00000395282;ENST00000506560;ENST00000505397	.	.	.	5.36	4.52	0.55395	.	0.469539	0.23997	N	0.042516	T	0.43166	0.1235	N	0.19112	0.55	0.50467	D	0.999876	B;B	0.29716	0.255;0.072	B;B	0.25987	0.065;0.029	T	0.41466	-0.9507	9	0.59425	D	0.04	-9.1263	14.0787	0.64907	0.0728:0.0:0.9272:0.0	.	67;67	Q6MZP7-2;Q6MZP7	.;LIN54_HUMAN	R	67	.	ENSP00000341947:T67R	T	-	2	0	LIN54	84124822	1.000000	0.71417	0.998	0.56505	0.195	0.23768	6.402000	0.73260	1.264	0.44198	0.655	0.94253	ACA	LIN54-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252626.2	54.43237	KEEP		-	64.469354	0.185185	20	88	---	---	---	---	1	0.5681454	6	4	0	121	21	96	0	121	2	0	0	0	0	0	0	21	96	0	121	2	TP
CLCN3	0	broad.mit.edu	37	4	170610366	170610366	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	g.chr4:170610366C>G	ENST00000513761.1	+	5	1150	c.591C>G	c.(589-591)atC>atG	p.I197M	CLCN3_ENST00000347613.4_Missense_Mutation_p.I197M|CLCN3_ENST00000504131.2_Missense_Mutation_p.I180M|CLCN3_ENST00000360642.3_Missense_Mutation_p.I197M	NM_001829.3	NP_001820.2	P51790	CLCN3_HUMAN	chloride channel, voltage-sensitive 3	197		NA		NA	endosomal lumen acidification	cell surface|early endosome membrane|Golgi membrane|integral to membrane|late endosome membrane|transport vesicle membrane	antiporter activity|ATP binding|PDZ domain binding|protein heterodimerization activity|protein homodimerization activity|voltage-gated chloride channel activity		NA	breast(5)|endometrium(3)|large_intestine(8)|lung(8)|ovary(1)|skin(1)|stomach(2)|upper_aerodigestive_tract(1)	29		Prostate(90;0.00601)|Renal(120;0.0183)		GBM - Glioblastoma multiforme(119;0.0233)|LUSC - Lung squamous cell carcinoma(193;0.131)	NA	CAGAATTAATCATAGGTCAAG	0.353		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													115	112	113	NA		NA	NA	4		NA		NA									NA				170610366		2203	4300	6503	SO:0001583	missense			ENSG00000109572	HGNC:2021		Approved	uc003ish.3	NA	D3DP34|O14918|Q86Z21	ENST00000513761.1	37	CCDS34101.1	.	.	.	.	.	.	.	.	.	.	C	9.479	1.097551	0.20552	.	.	ENSG00000109572	ENST00000513761;ENST00000347613;ENST00000360642;ENST00000504131;ENST00000507875	D;D;D;D;D	0.89617	-2.52;-2.54;-2.49;-2.51;-2.37	5.36	4.5	0.54988	Chloride channel, core (1);	0.000000	0.85682	D	0.000000	T	0.78717	0.4327	N	0.13003	0.285	0.52099	D	0.999946	B;B;B;B;B	0.17852	0.014;0.014;0.014;0.014;0.024	B;B;B;B;B	0.18561	0.01;0.01;0.01;0.01;0.022	T	0.70952	-0.4732	9	.	.	.	-6.2814	12.4148	0.55488	0.4653:0.5347:0.0:0.0	.	197;180;170;197;197	B7Z932;B9EGJ9;E9PE15;P51790;P51790-2	.;.;.;CLCN3_HUMAN;.	M	197;197;197;180;170	ENSP00000424603:I197M;ENSP00000261514:I197M;ENSP00000353857:I197M;ENSP00000424540:I180M;ENSP00000425323:I170M	.	I	+	3	3	CLCN3	170846941	1.000000	0.71417	0.999	0.59377	0.856	0.48823	1.712000	0.37940	1.214	0.43395	0.65	0.86243	ATC	CLCN3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000363210.2	30.722694	KEEP		+	38.7214	0.168831	13	64	---	---	---	---	1	0.9999231	13	73	0	81	15	71	0	81	2	0	0	0	0	0	0	15	71	0	81	2	TP
LRRC16A	55604	broad.mit.edu	37	6	25606465	25606465	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	g.chr6:25606465G>A	ENST00000329474.6	+	35	4179	c.3811G>A	c.(3811-3813)Gtc>Atc	p.V1271I		NM_001173977.1|NM_017640.5	NP_001167448.1|NP_060110.4	Q5VZK9	LR16A_HUMAN	leucine rich repeat containing 16A	1271		NA		NA	actin filament organization|blood coagulation|cell migration|lamellipodium assembly|ruffle organization|urate metabolic process	cytosol|lamellipodium|nucleus			NA	breast(4)|central_nervous_system(1)|endometrium(5)|kidney(3)|large_intestine(10)|lung(19)|ovary(2)|pancreas(1)|prostate(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	50					NA	AGCACGGCCCGTCATCCCGCA	0.607		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													36	43	41	NA		NA	NA	6		NA		NA									NA				25606465		1950	4146	6096	SO:0001583	missense			ENSG00000079691	HGNC:21581	NM_017640	Approved	uc011djw.2	NA	Q6ZUH5|Q6ZW07|Q9NXU7	ENST00000329474.6	37	CCDS54973.1	.	.	.	.	.	.	.	.	.	.	G	12.69	2.015041	0.35511	.	.	ENSG00000079691	ENST00000329474;ENST00000399313	T	0.14893	2.47	5.85	0.38	0.16222	.	0.534254	0.20328	N	0.094500	T	0.02230	0.0069	N	0.08118	0	0.58432	D	0.999999	B;B;B	0.20887	0.012;0.049;0.039	B;B;B	0.17979	0.008;0.014;0.02	T	0.37619	-0.9698	10	0.39692	T	0.17	-3.0286	3.9524	0.09375	0.5183:0.0:0.1758:0.3059	.	1271;1265;1226	Q5VZK9;B2RTQ5;Q5VZK9-2	LR16A_HUMAN;.;.	I	1271;1226	ENSP00000331983:V1271I	ENSP00000331983:V1271I	V	+	1	0	LRRC16A	25714444	0.002000	0.14202	0.943	0.38184	0.56	0.35617	1.393000	0.34497	0.033	0.15463	-0.15	0.13652	GTC	LRRC16A-001	NOVEL	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040045.2	2.806071	KEEP		+	6.5952	0.115385	3	23	---	---	---	---	1	0.9019428	2	36	0	37	3	24	0	37	2	0	0	0	0	0	0	3	24	0	37	2	TP
PTEN	5728	broad.mit.edu	37	10	89711900	89711900	+	Missense_Mutation	SNP	G	G	A	rs121913294		GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	g.chr10:89711900G>A	ENST00000371953.3	+	6	1875	c.518G>A	c.(517-519)cGc>cAc	p.R173H		NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	173	Phosphatase tensin-type.	NA	R -> C (in endometrial hyperplasia; loss of phosphatase activity towards Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3; retains ability to bind phospholipid membranes).|R -> H (loss of phosphatase activity towards Ins(1,3,4,5)P4).|R -> P (loss of phosphatase activity towards Ins(1,3,4,5)P4).	NA	activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.R173H(23)|p.R55fs*1(5)|p.?(4)|p.V166fs*17(3)|p.G165fs*9(3)|p.Y27fs*1(2)|p.G165_*404del(1)|p.R173P(1)|p.R172fs*5(1)	NA	NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)	NA	AGTCAGAGGCGCTATGTGTAT	0.348	R173H(RL952_ENDOMETRIUM)	31	"""D, Mis, N, F, S"""	NA	"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""	NA		Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10	10q23.3	5728	phosphatase and tensin homolog gene	NA	"""L, E, M, O"""	80	Whole gene deletion(37)|Substitution - Missense(24)|Deletion - Frameshift(11)|Unknown(4)|Complex - frameshift(3)|Deletion - In frame(1)	central_nervous_system(32)|prostate(17)|skin(8)|endometrium(5)|lung(4)|ovary(4)|haematopoietic_and_lymphoid_tissue(3)|breast(3)|testis(1)|soft_tissue(1)|urinary_tract(1)|kidney(1)	GRCh37	CM074465	PTEN	M	rs121913294						129	132	131	NA		NA	NA	10		NA		NA									NA				89711900		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	NA	B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	G	35	5.478054	0.96291	.	.	ENSG00000171862	ENST00000371953	D	0.98889	-5.21	5.74	5.74	0.90152	Phosphatase tensin type (1);	0.048960	0.85682	D	0.000000	D	0.99162	0.9710	M	0.84082	2.675	0.80722	D	1	D	0.89917	1.0	D	0.69824	0.966	D	0.99533	1.0961	9	.	.	.	0.9169	19.9308	0.97118	0.0:0.0:1.0:0.0	.	173	P60484	PTEN_HUMAN	H	173	ENSP00000361021:R173H	.	R	+	2	0	PTEN	89701880	1.000000	0.71417	1	0.80357	0.998	0.95712	9.370000	0.97159	2.722	0.93159	0.591	0.81541	CGC	PTEN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049241.1	22.362715	KEEP		+	37.037833	0.137931	16	100	---	---	---	---	1	0.9954029	13	42	0	150	18	110	0	150	2	1	1	141	434	2	355	18	110	0	150	10	TP
C11orf65	160140	broad.mit.edu	37	11	108302505	108302505	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	g.chr11:108302505G>A	ENST00000393084.1	-	3	211	c.142C>T	c.(142-144)Cgt>Tgt	p.R48C	C11orf65_ENST00000525729.1_Intron|C11orf65_ENST00000529391.1_Missense_Mutation_p.R48C	NM_152587.3	NP_689800.3	Q8NCR3	CK065_HUMAN	chromosome 11 open reading frame 65	48		NA		NA					NA	endometrium(1)|large_intestine(3)|lung(4)|ovary(2)	10		all_cancers(61;1.38e-11)|all_epithelial(67;3.16e-07)|Melanoma(852;2.55e-06)|Acute lymphoblastic leukemia(157;3.95e-05)|all_hematologic(158;0.00014)|Breast(348;0.0258)|all_neural(303;0.072)		Epithelial(105;8.21e-06)|BRCA - Breast invasive adenocarcinoma(274;1.01e-05)|all cancers(92;0.000189)|Colorectal(284;0.114)|OV - Ovarian serous cystadenocarcinoma(223;0.144)	NA	ACTATCTGACGTGGTTCTCCT	0.299		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													177	181	179	NA		NA	NA	11		NA		NA									NA				108302505		2201	4295	6496	SO:0001583	missense			ENSG00000166323	HGNC:28519	NM_152587	Approved	uc001pkh.3	NA	Q6PCA8	ENST00000393084.1	37	CCDS8340.1	.	.	.	.	.	.	.	.	.	.	G	15.94	2.981569	0.53827	.	.	ENSG00000166323	ENST00000529391;ENST00000393084;ENST00000533583	T;T;T	0.34275	1.37;1.37;1.37	5.73	4.82	0.62117	.	0.231873	0.35970	N	0.002878	T	0.36276	0.0961	M	0.64404	1.975	0.44976	D	0.997993	B	0.18610	0.029	B	0.16722	0.016	T	0.24941	-1.0146	10	0.72032	D	0.01	-2.4624	10.6225	0.45489	0.088:0.0:0.912:0.0	.	48	Q8NCR3	CK065_HUMAN	C	48	ENSP00000436400:R48C;ENSP00000376799:R48C;ENSP00000434500:R48C	ENSP00000376799:R48C	R	-	1	0	C11orf65	107807715	0.622000	0.27085	0.981	0.43875	0.382	0.302	3.196000	0.51020	1.442	0.47568	0.65	0.86243	CGT	C11orf65-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		-2.551142	KEEP		-	15.192878	0.073684	7	88	---	---	---	---	1	0.1432248	6	1	0	131	10	103	0	131	2	0	0	0	0	0	0	10	103	0	131	2	TP
RBM25	58517	broad.mit.edu	37	14	73578303	73578303	+	Silent	SNP	T	T	C			GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	g.chr14:73578303T>C	ENST00000261973.7	+	16	2370	c.2085T>C	c.(2083-2085)ttT>ttC	p.F695F	RBM25_ENST00000532483.1_3'UTR|RBM25_ENST00000527432.1_Silent_p.F695F	NM_021239.2	NP_067062.1	P49756	RBM25_HUMAN	RNA binding motif protein 25	695		NA		NA	apoptosis|mRNA processing|regulation of alternative nuclear mRNA splicing, via spliceosome|RNA splicing	cytoplasm|nuclear speck	mRNA binding|nucleotide binding|protein binding		NA	breast(2)|central_nervous_system(2)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(7)|lung(6)|ovary(2)|pancreas(1)	31				BRCA - Breast invasive adenocarcinoma(234;0.00362)|OV - Ovarian serous cystadenocarcinoma(108;0.0688)	NA	ATAGTGTCTTTAACAAATTTG	0.403		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													105	103	104	NA		NA	NA	14		NA		NA									NA				73578303		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000119707	HGNC:23244	XM_027330	Approved	uc001xno.3	NA	A0PJL9|B2RNA8|B3KT03|Q2TA72|Q5XJ17|Q6P665|Q9H6A1|Q9UEQ5|Q9UIE9	ENST00000261973.7	37	CCDS32113.1												NA	NA	NA								NA	NA	NA																													NA	NA															NA			NA	NA	NA	NA			NA	NA	NA	NA		RBM25-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000394966.1	62.065816	KEEP		+	66.607243	0.25	20	60	---	---	---	---	1	1	30	97	0	131	22	62	0	131	2	0	0	0	0	0	0	22	62	0	131	2	TP
ADAM10	102	broad.mit.edu	37	15	58904096	58904096	+	Missense_Mutation	SNP	A	A	C			GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	g.chr15:58904096A>C	ENST00000260408.3	-	12	2049	c.1606T>G	c.(1606-1608)Tgt>Ggt	p.C536G	ADAM10_ENST00000561288.1_Intron|ADAM10_ENST00000402627.1_Intron|ADAM10_ENST00000396140.2_Missense_Mutation_p.C235G	NM_001110.2	NP_001101.1	O14672	ADA10_HUMAN	ADAM metallopeptidase domain 10	536	Disintegrin.	NA		NA	cell-cell signaling|constitutive protein ectodomain proteolysis|epidermal growth factor receptor signaling pathway|in utero embryonic development|integrin-mediated signaling pathway|monocyte activation|negative regulation of cell adhesion|Notch receptor processing|Notch signaling pathway|PMA-inducible membrane protein ectodomain proteolysis|positive regulation of cell growth|positive regulation of cell proliferation|positive regulation of T cell chemotaxis|protein phosphorylation|response to tumor necrosis factor	cell surface|endomembrane system|Golgi-associated vesicle|integral to membrane|nucleus|plasma membrane	integrin binding|metalloendopeptidase activity|protein homodimerization activity|protein kinase binding|SH3 domain binding|zinc ion binding		NA	breast(1)|endometrium(1)|kidney(5)|large_intestine(3)|lung(11)|ovary(1)|prostate(2)|skin(3)	27				GBM - Glioblastoma multiforme(80;0.202)	NA	AAGCCATTACATATTCCTTCC	0.448		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													162	128	139	NA		NA	NA	15		NA		NA									NA				58904096		2192	4292	6484	SO:0001583	missense			ENSG00000137845	HGNC:188	NM_001110	Approved	uc002afd.1	NA	Q10742|Q92650	ENST00000260408.3	37	CCDS10167.1	.	.	.	.	.	.	.	.	.	.	A	17.49	3.403694	0.62288	.	.	ENSG00000137845	ENST00000260408;ENST00000396136;ENST00000396140	T;T	0.64438	-0.1;-0.1	5.92	5.92	0.9559	Blood coagulation inhibitor, Disintegrin (5);	0.000000	0.85682	D	0.000000	D	0.88016	0.6324	H	0.98996	4.395	0.80722	D	1	D;D;D	0.89917	1.0;1.0;1.0	D;D;D	0.97110	1.0;1.0;1.0	D	0.92825	0.6275	10	0.87932	D	0	-19.2504	16.3678	0.83341	1.0:0.0:0.0:0.0	.	235;355;536	B4DU28;A8MY20;O14672	.;.;ADA10_HUMAN	G	536;355;235	ENSP00000260408:C536G;ENSP00000379444:C235G	ENSP00000260408:C536G	C	-	1	0	ADAM10	56691388	1.000000	0.71417	0.901	0.35422	0.202	0.24057	8.962000	0.93254	2.254	0.74563	0.528	0.53228	TGT	ADAM10-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255880.2	14.669722	KEEP		-	22.026833	0.137931	8	50	---	---	---	---	1	0.9993789	11	98	0	89	8	55	0	89	2	0	0	0	0	0	0	8	55	0	89	2	TP
SNX29	92017	broad.mit.edu	37	16	12220512	12220512	+	Silent	SNP	G	G	A			GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	g.chr16:12220512G>A	ENST00000566228.1	+	12	1494	c.1425G>A	c.(1423-1425)gtG>gtA	p.V475V	SNX29_ENST00000306030.3_Silent_p.V90V|SNX29_ENST00000323433.4_Silent_p.V90V	NM_032167.3	NP_115543.3	Q8TEQ0	SNX29_HUMAN	sorting nexin 29	90		NA		NA	cell communication		phosphatidylinositol binding		NA	endometrium(1)|large_intestine(1)|lung(3)|ovary(1)|prostate(1)	7					NA	AGGCCACTGTGGCCATGATGA	0.488		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													127	128	128	NA		NA	NA	16		NA		NA									NA				12220512		2010	4182	6192	SO:0001819	synonymous_variant			ENSG00000048471	HGNC:30542		Approved	uc002dby.5	NA	B5MDW2|Q8N2X2	ENST00000566228.1	37	CCDS10553.2												NA	NA	NA								NA	NA	NA																													NA	NA															NA			NA	NA	NA	NA			NA	NA	NA	NA		SNX29-005	PUTATIVE	not_organism_supported|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000422622.1	7.583478	KEEP		+	10.113161	0.166667	4	20	---	---	---	---	1	0.860726	3	17	0	45	5	24	0	45	2	0	0	0	0	0	0	5	24	0	45	2	TP
GTF3C1	2975	broad.mit.edu	37	16	27480738	27480738	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-2510-Tumor-SM-1Y48V	GBM-TCGA-28-2510-Normal-SM-1Y48Q	g.chr16:27480738C>T	ENST00000356183.4	-	32	4963	c.4948G>A	c.(4948-4950)Ggc>Agc	p.G1650S	GTF3C1_ENST00000561623.1_Missense_Mutation_p.G1650S	NM_001520.3	NP_001511.2	Q12789	TF3C1_HUMAN	general transcription factor IIIC, polypeptide 1, alpha 220kDa	1650		NA		NA		transcription factor TFIIIC complex	DNA binding|protein binding		NA	breast(2)|central_nervous_system(4)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(14)|liver(3)|lung(28)|ovary(2)|pancreas(1)|prostate(2)|skin(5)|upper_aerodigestive_tract(2)	80					NA	GAGTAGTAGCCCCTCATCAGC	0.602		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													151	115	127	NA		NA	NA	16		NA		NA									NA				27480738		2197	4300	6497	SO:0001583	missense				HGNC:4664	NM_001520	Approved	uc002dov.2	NA	B2RP21|Q12838|Q6DKN9|Q9Y4W9	ENST00000356183.4	37	CCDS32414.1	.	.	.	.	.	.	.	.	.	.	C	34	5.395837	0.96009	.	.	ENSG00000077235	ENST00000356183;ENST00000388971	T	0.37752	1.18	4.36	4.36	0.52297	.	0.000000	0.85682	D	0.000000	T	0.61862	0.2381	M	0.77616	2.38	0.54753	D	0.999988	D;D	0.89917	0.998;1.0	D;D	0.97110	0.988;1.0	T	0.67921	-0.5545	10	0.66056	D	0.02	-13.7291	16.7036	0.85366	0.0:1.0:0.0:0.0	.	1650;1650	Q12789;Q12789-3	TF3C1_HUMAN;.	S	1650;1646	ENSP00000348510:G1650S	ENSP00000348510:G1650S	G	-	1	0	GTF3C1	27388239	1.000000	0.71417	1	0.80357	0.96	0.62799	7.114000	0.77103	2.266	0.75297	0.491	0.48974	GGC	GTF3C1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000433856.1	3.102808	KEEP		-	7.643582	0.103448	3	26	---	---	---	---	1	0.9973015	28	130	0	30	3	27	0	30	2	0	0	0	0	0	0	3	27	0	30	2	TP
